143 related articles for article (PubMed ID: 32525129)
21. The past: what we have learned in the last decade.
Borchmann P; Engert A
Hematology Am Soc Hematol Educ Program; 2010; 2010():101-7. PubMed ID: 21239778
[TBL] [Abstract][Full Text] [Related]
22. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
[TBL] [Abstract][Full Text] [Related]
23. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma.
Bates JE; Parikh RR; Mendenhall NP; Morris CG; Hoppe RT; Constine LS; Hoppe BS
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):522-529. PubMed ID: 32173399
[TBL] [Abstract][Full Text] [Related]
25. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
[TBL] [Abstract][Full Text] [Related]
26. A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: the role of ABVD in daily practice.
Andjelic B; Antic D; Jakovic L; Todorovic M; Bogdanovic A; Djurasinovic V; Bila J; Mihaljevic B
Eur J Haematol; 2014 Nov; 93(5):392-9. PubMed ID: 24797378
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding EJ; Advani R; Rosenberg SA; Hoppe RT
Radiother Oncol; 2018 Dec; 129(3):507-512. PubMed ID: 30539763
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.
Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival of a patient with human immunodeficiency virus infection and Hodgkin's lymphoma.
Diwan AH; Umbreit J; Nelson BP
South Med J; 2002 Aug; 95(8):943-4. PubMed ID: 12190241
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.
Ansell SM
Am J Hematol; 2012 Dec; 87(12):1096-103. PubMed ID: 23151980
[TBL] [Abstract][Full Text] [Related]
31. ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.
Roberts KB; Younes A; Hodgson DC; Advani R; Dabaja BS; Dhakal S; Flowers CR; Ha CS; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP; Shapiro R; Smith SM; Terezakis SA; Winkfield KM; Constine LS;
Am J Clin Oncol; 2016 Aug; 39(4):384-95. PubMed ID: 27299425
[TBL] [Abstract][Full Text] [Related]
32. Management of Hodgkin lymphoma.
Ansell SM; Armitage JO
Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
[TBL] [Abstract][Full Text] [Related]
33. XVII. Treatment of advanced-stage Hodgkin lymphoma.
Engert A
Hematol Oncol; 2015 Jun; 33 Suppl 1():87-9. PubMed ID: 26062063
[No Abstract] [Full Text] [Related]
34. Spontaneous Regression of Hodgkin Lymphoma: Case Report and Review of the Literature.
Pasvolsky O; Berger T; Bernstine H; Hayman L; Raanani P; Vidal L
Acta Haematol; 2019; 141(1):14-18. PubMed ID: 30439716
[TBL] [Abstract][Full Text] [Related]
35. Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry.
Myint ZW; Shrestha R; Siddiqui S; Slone S; Huang B; Ramlal R; Monohan GP; Hildebrandt GC; Saeed H
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):17-22. PubMed ID: 31629724
[TBL] [Abstract][Full Text] [Related]
36. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and outcome of pediatric patients with stage IV Hodgkin lymphoma.
Belgaumi A; Al-Kofide AA; Khafaga Y; Joseph N; Jamil-Malik R; Siddiqui KS; Sabbah RS
Hematol Oncol Stem Cell Ther; 2009; 2(1):278-84. PubMed ID: 20063558
[TBL] [Abstract][Full Text] [Related]
38. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Torok JA; Wu Y; Prosnitz LR; Kim GJ; Beaven AW; Diehl LF; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):54-9. PubMed ID: 25863754
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases.
Laurent C; Do C; Gourraud PA; de Paiva GR; Valmary S; Brousset P
Medicine (Baltimore); 2015 Jun; 94(25):e987. PubMed ID: 26107683
[TBL] [Abstract][Full Text] [Related]
40. First-line treatment of Hodgkin's lymphoma.
Klimm B; Engert A; Diehl V
Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
